Myocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2
Rate of myocarditis higher after receipt of mRNA-1273, particularly for younger men (younger than 40 years)
Diagnosis & Disease Information
FDA Clears Bodyport Cardiac Scale to Monitor Heart Function, Fluid Status
The Bodyport Cardiac Scale is designed to detect signals through an individual’s feet to noninvasively measure a broad spectrum of hemodynamic biomarkers for heart function and fluid status.
FDA to Review Wearable Furosemide Delivery System for Outpatient Use
Furoscix is a wearable, pre-programmed on-body furosemide delivery system for outpatient self-administration.
Trial Evaluating Pemafibrate to Reduce CV Outcomes in Diabetes Patients Discontinued
Pemafibrate is an investigational selective peroxisome proliferator activator receptor-alpha modulator (SPPARMα).
Mavacamten Evaluated in Patients With Obstructive Hypertrophic Cardiomyopathy Eligible for SRT
The VALOR-HCM trial evaluated the effects of mavacamten in over 100 patients with symptomatic obstructive HCM (NYHA class III-IV) who met the guideline criteria for SRT and had been referred for an invasive procedure.
Vasostrict Now Available in Ready-to-Use Formulation
The new formulation is expected to save preparation time.
FDA Supports Qualified Health Claim for Magnesium and Reduced Hypertension Risk
The strength of the scientific evidence supporting the relationship will be disclosed as “supportive but inconclusive” to avoid misleading consumers.
Possible Defective Delivery System Prompts Recall of Nitroglycerin Lingual Spray
Nitroglycerin Lingual Spray is indicated for the acute relief of an attack or prophylaxis of chest pain due to coronary artery disease in adult patients.
Aficamten Gets Breakthrough Tx Status for Obstructive Hypertrophic Cardiomyopathy
The designation was based on data from the phase 2 REDWOOD-HCM trial.
Drugs Prescribed Widely for Common Conditions Linked to Orthostatic Hypotension
The meta-analysis included 69 RCTs with a total of 27,079 patients.
